FAQs: GLP-1 Agonists (Semaglutide)
- How can I get quick information on how to offer semaglutide/tirzepatide?
A. You can view our previous webinar on semaglutide/tirzepatide, or visit this article for additional medical context. - How do I order semaglutide/tirzepatide?
- Please complete this form to confirm your understanding and agreement with the requirements to offer semaglutide/tirzepatide. After completing the form, please submit a ticket to proceed with your first semaglutide/tirzepatide order. Our inventory team will place your order and the ops team will add it to your booking link for future appointments.
How long does shipping typically take?- Semaglutide/tirzepatide is usually shipped for overnight delivery on Mondays or Tuesdays after ordering. Depending on when you place your order, it can range anywhere from 2-7 business days.
- How do I start offering this to patients?
- Detailed clinical workflow is in the P&P here. The process varies slightly for existing patients or new patients:
For existing patients:
- All providers must capture the information in the provided consult template or create their own template capturing the same information. We recommended printing copies to have in your studio for easy access. We’ve also created a follow-up note template to help you consistently and thoroughly document patient visits.
- Take a photo of the completed intake form and attach it to the patient’s chart in the EHR.
- Once the photo is attached to the patient’s chart:
- For RN providers: alert your PCC and Frances in Tiger, and wait for clearance before proceeding.
If you have your own clearing provider, notify them so they can clear the patient.
Once cleared, the patient will review and sign the consent form. You'll administer the first injection, provide the patient with at least 1 month of product in pre-drawn syringes, and complete the semaglutide/tirzepatide procedure note (or make your own and enter it). - For NP/PA providers: confirm the patient is a candidate. Then, the patient will review and sign the consent form. You'll administer the first injection, provide the patient with 1-3 months of product in pre-drawn syringes, and complete the semaglutide/tirzepatide procedure note (or make your own and enter it).
- For RN providers: alert your PCC and Frances in Tiger, and wait for clearance before proceeding.
For new patients:
Two new optional weight loss fields have been added to the new patient onboarding flow. Patients will see the following questions when creating a medical profile:
- Are you interested in weight loss products?
- Please provide height/weight
This will help indicate their interest in semaglutide/tirzepatide and also streamline future medical clearances.
Ensure patient attests to the following during their visit (please note these are also included in the consent form provided to you):
- BMI>25 to start treatment, BMI>21 for maintenance treatment
- No personal or family history of multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Not type 1 diabetic or type 2 diabetic requiring medications
- No history of thyroid cancer
- No history of pancreatitis
- Not pregnant or intending to become pregnant in the next two months
- Not currently on another hypoglycemic agent (e.g. metformin) -- > these patients are not candidates and should be managed by their primary care provider
Q. What ancillaries should I have on hand to offer semaglutide/tirzepatide?
A. You will need extra needles and syringes on hand to give to the patient and bacteriostatic water for reconstitution. These are available in your Medline account.